Breaking: Medicare selects next 15 drugs for price negotiations
View online | Sign up
 
Jan.​ 17,​ 2025

Breaking News

 

headshot By Ned Pagliarulo
 
 
 
 
 

More Than A Newsletter

 
 

Related Publications

Healthcare Dive | MedTech Dive
 

Connect With Us

X/Twitter | Facebook | LinkedIn
 

Editorial

Contact an editor | Meet the team
 

Advertising

Contact our team
 

About BioPharma Dive

BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma. The newsletter and website cover topics ranging from clinical readouts to FDA approvals, gene therapy to drug pricing and M&A to research partnerships.


BioPharma Dive is a leading industry publication operated by Informa TechTarget. Our business journalists spark ideas and shape agendas for 14 million decision makers in competitive industries.

 
Sign up for the newsletter
 

This email is optimized for display on mobile phones. This BioPharmaDive breaking news alert is a product of TechTarget, Inc. and its subsidiaries, 275​ Grove Street, Newton, Massachusetts, 02466 US. We value your privacy. We won’t share your email address with anyone else without your permission. This message was sent to npkvdejmf6@niepodam.pl. You can unsubscribe anytime. See our full privacy policy.
 

Sign up | Manage subscription | Advertise with us | Submit story tip

 
 
 

This site is owned and operated by TechTarget, Inc. and its subsidiaries.